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Abstract
Background: Compared to the general elderly population, those institutionalized in LTC facilities have the highest
prevalence of osteoporosis and subsequently have higher incidences of vertebral and hip fractures. The goal of this
study is to determine how well nurses at LTC facilities are educated to properly administer bisphosphonates. A
secondary question assessed was the nurse’s and PSW’s attitudes and beliefs regarding the role and benefits of
vitamin D for LTC patients.
Methods: Eight LTC facilities in Hamilton were surveyed, and all nurses were offered a survey. A total 57 registered
nurses were surveyed. A 21 item questionnaire was developed to assess existing management practices and
specific osteoporosis knowledge areas.
Results: The questionnaire assessed the nurse’s and personal support worker’s (PSWs) education on how to
properly administer bisphosphonates by having them select all applicable responses from a list of options. These
options included administering the drug before, after or with meals, given with or separate from other
medications, given with juice, given with or without water, given with the patient sitting up, or finally given with
the patient supine. Only 52% of the nurses and 8.7% of PSWs administered the drug properly, where they selected
the options: (given before meals, given with water, given separate from all other medications, and given in a
sitting up position). If at least one incorrect option was selected, then it was scored as an inappropriate
administration. Bisphosphonates were given before meals by 85% of nurses, given with water by 90%, given
separately from other medication by 71%, and was administered in an upright position by 79%. Only 52% of the
nurses and 8.7% of PSWs surveyed were administering the drug properly. Regarding the secondary question, of the
57 nurses surveyed, 68% strongly felt their patients should be prescribed vitamin D supplements. Of the 124 PSWs
who completed the survey, 44.4% strongly felt their patients should be prescribed vitamin D supplementation.
Conclusion: Bisphosphonates are quite effective in increasing the bone mineral density of LTC patients, and may
reduce fracture rates, but it is only effective if properly administered. In our study, proper administration of
bisphosphonate therapy was less than optimal. In summary, although the education of health providers has
improved since the mid-1990’s, this area still requires further attention and the subject of future quality assurance
research.
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Osteoporosis is a disease leading to progressive
decreases in bone mineral density (BMD), decreased
bone strength and increased risk of skeletal fractures
[1]. Specifically, vertebral and hip fractures pose devas-
tating consequences for the osteoporotic patients.
Approximately 30% of women will have sustained at
least one vertebral fracture by the age of 75 [2]. There
are over 700,000 incident vertebral fractures related to
osteoporosis each year in the United States [2]. The esti-
mated number of hip fractures worldwide in the year
2050 is estimated to increase to 6.3 million [3]. Both
vertebral and hip fractures are associated with an
increase mortality rate [4,5]. Therapy for osteoporosis
may reduce mortality rates based on recent studies [6,7],
it is crucial to emphasize the impact a vertebral or hip
fracture can have. Approximately 75% of patients who
present with a clinical vertebral fracture will experience
chronic pain [8]. Vertebral fractures also have a signifi-
cant impact on quality of life and functional impairment
on the affected patients [9] and results in increased
acute care use, analgesic use and higher care needs [10].
An important population to consider is the patients
living in long term care (LTC) facilities. Compared to
the general elderly population, those institutionalized
have the highest prevalence of osteoporosis. Rates have
been estimated to be as high as 79% in males and 86%
in females over the age of 85 [11], and this translates to
a higher incidence of fragility fractures. The annual inci-
dence of hip fractures in LTC patients is estimated to
be 4% (with a range of 2.3% to 6% annually) [12,13].
This annual incidence is estimated to be 3 to 11 times
higher than similar aged individuals who live in the
community [14,15]. It is also estimated that a vertebral
fracture is present in 50% of LTC residents [16]. Elderly
LTC residents have a 40% risk of death within 1 year
after sustaining a hip fracture [17].
Canadian wide clinical practice guidelines do not spe-
cifically address the LTC population. However the
unique needs of this population have been addressed by
a consensus guide developed in Quebec. Global recom-
mendations included: vitamin D, calcium, a comprehen-
sive exercise program and the initiation of
pharmacological treatment for residents at high risk.
Specific recommendations are provided for screening,
laboratory tests for secondary causes of osteoporosis
and starting treatment including non-pharmacologic
interventions, pharmacological treatments, and nutri-
tional supplementation [18]. Although osteoporosis pose
such a burden on these patients and the healthcare sys-
tem, there remains a significant care gap between what
are accepted to be recommended treatments and actual
practice [18].
Aside from the physicians at the LTC facilities, the
front line staffs (including the nurses and PSWs) plays a
key role in influencing osteoporosis care in these facil-
ities, and thereby helping to prevent future fractures in
this high risk population. If properly educated on the
risk of their patients to incur a fracture, and the current
recommendations for these high risk patients, the front
line staff has the ability to improve care through ensur-
ing the recommendations are implemented, through
education of the patients and families regarding fracture
prevention, advocacy for their patients to ensure proper
therapies are delivered, among other possibilities.
Currently, there is limited research on the perspectives
of LTC staff on attitudes, practices and beliefs regarding
osteoporosis awareness, management and fracture pre-
vention. Several studies have investigated the attitudes
and practices of the LTC facility administrative staff and
physicians but there is currently limited research regard-
ing the perspectives of the front-line staff. It is impor-
tant to assess the current practice and education of
front-line staff, as efficacious therapies and preventative
strategies are not effective unless they are implemented
and properly administered. The goal of this study is to
determine how well nurses and PSWs) at LTC facilities
are educated to properly administer bisphosphonates. A
secondary question assessed was the nurse’sa n dP S W ’s
attitudes and beliefs regarding the role and benefits of
vitamin D for LTC patients.
Methods
Study Population
Eight LTC facilities in Hamilton (Ontario, Canada) were
surveyed. All front line staff who worked day shifts at
each of these facilities was offered a survey. Those we
aimed to include into the study included directors of
care, directors of nursing, administrators, nurse educa-
tors, charge nurses, nurse practitioners, registered
nurses, registered nursing assistants, physiotherapists,
personal support workers, and students who trained at
these facilities. Non-front-line staff and those who
worked primarily night shifts were excluded from the
study. For the current study we examined responses for
the nurses and personal support workers. Personal sup-
port workers were individuals employed by the LTC
facilities who aided with the resident’s activities of daily
living, which included medication administration among
other activities. None of LTC staff surveyed were
exposed to any specific education initiatives regarding
osteoporosis management or fracture prevention. Also,
the LTC staff members surveyed worked at different
facilities from the ones associated with the study investi-
gators. This study was approved by the local research
ethics board at Hamilton Health Sciences.
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The project coordinator contacted each LTC home to
introduce the survey to the administrator and scheduled
a date to administer the questionnaire. The project
coordinator was present for the administration of the
questionnaire. The questionnaire’s main objectives were
to assess attitudes towards the link between osteoporosis
and falls; existing management practices and specific
osteoporosis knowledge areas. Item generation resulted
from three sources: literature review, input from key
informants and the team’s clinical experience. Questions
were reviewed and revised by content experts in clinical
content and methodology, and face validity was
reviewed by content experts. A 7 point Likert Scale was
used to scale responses. It allowed for the collection of
continuous data, which provides a gain in reliability
compared to dichotomous responses [19]. The 7 point
scale maximizes the amount of information, which most
individuals can discriminate, compensates for both
potential end aversion and loss of data, and reduces
floor or ceiling effects [19]. The questionnaire was
piloted to a convenience sample of front-line and
administrative staff working with the investigators to
check for clarity, readability and question relevance as
well as time for completion of the questionnaires. Sug-
gestions were incorporated into the final version where
appropriate.
Statistical Analysis
Descriptive statistics were calculated for facility charac-
teristics and distributions of item scores. Descriptive
data of the item scores were reported as percentages for
both the RN and PSW groups. All statistical analyses
were conducted on a personal computer running Win-
dows XP Professional using SAS 9.12 statistical software.
Results
A total of 57 nurses were surveyed from the 8 LTC
facilities. This group consisted of 20 registered nurses,
30 registered practical nurses, 1 nurse practitioner, 1
nurse manager, 1 nurse educator, 2 charge nurses, and 2
directors of nursing care. Of the 57 nurses, 48 were
responsible for medication administration to the
patients, and thus were included in the analysis of
bisphosphonate administration. However, all 57 nurses
were included in the analysis of the secondary question,
assessing their attitudes and beliefs of vitamin D supple-
mentation in LTC. Also surveyed were 124 PSWs
employed by the LTC facilities. Of this total, 23 PSWs
were responsible for administering medications to LTC
patients and were included in the analysis assessing
bisphosphonate administration. However, all 124 PSWs
were included in the analysis of the secondary question.
The average age of the LTC staff surveyed was 45.2
years, with an average of 12.7 years experience working
in the LTC setting, and 3.6 years of post-secondary edu-
cation. The completion rate was 100%, as the project
coordinator was present when the surveys were distribu-
ted, and waited for all of the RNs and PSWs to com-
plete the survey.
The questionnaire assessed the nursing staff’s educa-
tion to properly administer bisphosphonates by having
them select all applicable responses from a list of
options (Table 1). These options included administering
the drug before meals, after meals, with meals, given
with other medications, separated from other medica-
tions, given with juice, with or without water, given with
the patient sitting up, or while lying down. Only 52%
(25 out of 48) of the nurses administered the drug prop-
erly, where they selected the options: (given before
meals, with water, separated from all other medications,
and in an upright position) (Table 1). If at least one
incorrect option was selected, it was considered inap-
propriately administered. For nurses who administered
bisphosphonates inappropriately, the most common
mistake was administering the bisphosphonates concur-
rently with other medications, which was seen in 10.4%
(5 out of 48) of the nurses surveyed. In addition, 4.2% (2
out of 48) of the nurses gave the bisphosphonates after
meals, 2.1% (1 out of 48) gave it with meals, and 2.1%
(1 out of 48) each gave the medication while the resi-
dent was lying down, with juice, or without water. Upon
review of the data collected from the PSWs, only 8.7%
(2 out of 23) of those surveyed administered the bispho-
sphonate correctly. Like the nurses, the most common
mistake was administering the bisphosphonate concur-
rently with other medications, seen in 26.1% (6 out of
23) of PSWs. In addition, 17.4% (4 out of 23) each
administered the drug with meals and after meals, 4.4%
(1 out of 23) administered it without water, and 21.7%
(5 out of 23) administered it with juice. Finally 13% of
the PSWs administered the drug while the patient was
lying down.
The secondary question of this study was to assess the
nurse’sa n dP S W ’s attitudes and knowledge regarding
the benefits provided by Vitamin D supplementation
(Table 2). The survey included 5 questions, 1 of which
assessed the nurse’s attitudes regarding if their patients
should receive Vitamin D supplementation, and the
other 4 assessed their knowledge regarding Vitamin D
physiology and benefits. The questions were scored on a
7 point scale (with 1 point corresponding to strongly
disagree with the statement, and 7 points corresponding
to strongly agree). Of the 57 nurses surveyed, 68% (39
out of 57) strongly felt their patients should be pre-
scribed vitamin D supplements. Our definition of
“strongly agrees” corresponded to a score of either 6 or
7 on the 7-point scale. Regarding the nurse’s knowledge
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improves calcium absorption, 40.3% (23 out of 57)
believed it reduces falls, 42.1% (24 out of 57) believed it
improved balance, and 68.4% (39 out of 57) believed it
reduced fracture rates. The PSW population was also
surveyed with the same questionnaire. Of the 124 PSWs
who completed the survey, 44.4% strongly felt their
patients should be prescribed vitamin D supplementa-
tion. From that total, 86.3% believed vitamin D improves
calcium absorption, 29.8% believed it reduces falls,
39.5% believed it improved balance, and 56.5% believed
it reduced fracture rates.
Discussion
Osteoporosis management in the LTC facility is not
optimal. This is an important issue since LTC residents
have a higher incidence of osteoporosis and a higher
rate of fracture. Aside from the great impact on the
patient’s health-related quality of life, fractures also pose
a great economic consequence, which poses a large bur-
den on the healthcare system. The estimated one year
cost to the healthcare system for a hip fracture sustained
in a LTC facility is about $33,000 (Canadian) [20].
Our study shows that at least for the LTC facilities in
the Hamilton area, there is still much work to be done
in regards to educating the front-line workers. The
proper administration of bisphosphonates poses impor-
tant implications in regards to both drug efficacy, and in
preventing rate of adverse events. Only 52% of nurses
surveyed administered the bisphosphonates properly.
However, this is significantly better than the personal
support workers who also administer medications, who
had an alarming rate of 8.7% who correctly administer
the medication. Bisphosphonate administration is com-
plex, and it must be taken with a full glass of water,
while fasting, and the patient must remain in an upright
position for 30 to 60 minutes after administration for
prevention of esophageal erosion and ensuring adequate
absorption. In residents who are bed bound, and unable
to remain in an upright position, or have swallowing dif-
ficulties, the risk of harm out-weighs the benefits of
treatment.
Bisphosphonates have a well-established role in the
treatment of patients with osteoporosis. They have been
shown to improve both BMD values and also provide a
reduction in both vertebral and non-vertebral fracture
rates in community dwelling osteoporotic patients [21].
Currently, there is no clear evidence supporting the effi-
cacy of bisphosphonate use in the LTC population, but
there has been some data which suggests it may be ben-
eficial. Greenspan et al assessed the use of a bispho-
sphonate in the LTC population [22]. This trial
Table 1 The assessment of bisphosphonate administration techniques in nurses and personal support workers in the
long-term care setting
Assessment of the proper administration of bisphosphonates
RN Response Rate (n = 48) PSW Response Rate (n = 23)
Appropriate use of bisphosphonates 52.1% (25/48) 8.7% (2/23)
Given before meals 85.4% (41/48) 30.4% (7/23)
Given after meals 4.2% (2/48) 17.4% (4/23)
Given with meals 2.1% (1/48) 17.4% (4/23)
Given with other medications 10.4% (5/48) 26.1% (6/23)
Given separate from other medications 70.8% (34/48) 17.4% (4/23)
Given with juice 2.1% (1/48) 21.7% (5/23)
Given with water 89.6% (43/48) 39.1% (9/23)
Given without water 2.1% (1/48) 4.4% (1/23)
Given while the resident is sitting up 79.2% (38/48) 39.1% (9/23)
Given while the resident is lying down 2.1% (1/48) 13.0% (3/23)
Do not know (Did not select any available options) 2.1% (1/48) 43.5% (10/23)
Table 2 Beliefs of nurses and personal support workers regarding vitamin D physiology and benefits
Beliefs regarding benefits of vitamin D supplementation
RN Response Rate (n = 57) PSW Response Rate (n = 124)
Help with absorption of calcium 96.5% (55/57) 86.3% (107/124)
Reduce falls 40.4% (23/57) 29.8% (37/124)
Help with balance 42.1% (24/57) 39.5% (49/124)
Reduce fractures 68.4% (39/57) 56.5% (70/12)
Lau et al. BMC Geriatrics 2010, 10:73
http://www.biomedcentral.com/1471-2318/10/73
Page 4 of 7randomized 327 patients from 25 LTC facilities to either
treatment with alendronate 10 mg daily, or placebo. The
alendronate group had a significantly greater increase in
BMD at 24 months follow up compared to the placebo
group at both the lumbar spine (4.4% difference [95%
CI 3.3-5.5%]) and femoral neck (3.4%, [95% CI 2.3-
4.4%]) [20]. However, this study was not powered to
detect a difference in fracture rates. Furthermore, in a
recent Cochrane systematic review and meta-analysis,
alendronate was shown to reduce the risk of hip fracture
in high risk secondary prevention populations [23].
From this, it can be extrapolated that bisphosphonates
may reduce hip fractures when used in the LTC popula-
tion for secondary prevention [24]. There is currently
no evidence to show what impact improperly adminis-
tered bisphosphonates have on the drug’se f f i c a c yi n
regards to impact on BMD values or in fracture preven-
tion. However, this will be an interesting and important
clinical question, particularly in this specific population.
Our study also found that there is significant work to
be done in educating LTC frontline staff on strategies
and therapies that can reduced fracture rates in their
patients. We found that only 68% of nurses and 44.4%
of PSWs surveyed strongly felt their patients should be
prescribed vitamin D supplements. Similarly, based on
the surveyed responses, their knowledge regarding vita-
min D’s benefits and physiology could also be improved
through educational initiatives.
Improving the front-line staff’s knowledge regarding
fracture prevention, falls prevention, and benefits of
known therapies may change clinical practice, is also an
area for future focus. As an example, our group con-
ducted a study assessing the use of educational proto-
cols to improve the knowledge of family physicians in
regards to evidence-based osteoporosis management and
fracture risk factors [25]. After 1 year, the family physi-
cian’s awareness of their patient’s risk factors increased,
and the utilization of bone mineral density testing in the
high risk fracture group significantly increased as well.
Similarly, educational programs can be established for
nursing staff and other front line LTC members to
increase knowledge about fracture risk, prevention, and
proper management LTC patients, and this is an area of
future research interest for our group.
There are multiple factors attributing to this higher
fracture rate, and it is not solely accounted for by the
higher incidence of osteoporosis in this population. The
LTC population suffers from a higher rate of falls,
which is a risk factor for incurring fractures [26,27].
About 1 in 3 individuals above the age of 75 will incur a
fall each year [28]. This population also has a higher
rate of dementia, which is associated with an increased
risk of falls [29], and also has a higher prevalence of
vitamin D deficiency [30]. Furthermore, compared to
individuals living in the community, those living in LTC
facilities are less likely to recover functional capacity
after suffering a hip fracture [31]. Predictors of osteo-
porosis management in LTC residents have been
reported. Factors negatively associated with LTC resi-
dents receiving osteoporosis therapy include having six
or more co-morbidities, wheel chair use, depression,
cognitive impairment [30]. It is important to identify
risk factors for fractures in this population, and barriers
to care, but the next step is to address these issues.
Many of these risk factors can targeted, so similar edu-
cation initiatives as described above can be implemented
to educate the LTC staff, and may lead to a change clin-
ical practice.
Prior studies have shown there is a definite care gap
between current recommendations compared to the
actual practices in these LTC facilities. Calcium and Vita-
min D supplementation have been shown to have signifi-
cant benefits in preventing hip fractures and falls in LTC
residents [32]. However, even though this is quite well
established and accepted, there were an alarmingly low
percentage of LTC residents receiving either of these
supplementations. A Canadian study assessing 3 LTC
facilities found calcium supplementation in 26% of
patients, and Vitamin D supplementation in 30% of
patients [33]. The rates in the USA are slightly higher,
but are still not up to expected rates [34]. Furthermore, a
recent retrospective review of 17 Canadian LTC facilities
f o u n dt h a ta m o n gr e s i d e n t so v e r6 5y e a r so l dw i t ha
prior diagnosis of osteoporosis, or documented fracture
(either a prior vertebral fracture or any fracture within
180 days), only 38% of these residents were on a bispho-
sphonate [35]. Also, only 27.3% of these residents were
on vitamin D and calcium supplements [35]. Another
study reviewing the health records of 67 LTC facilities in
North Carolina and Arizona examined residents with a
prior diagnosis of osteoporosis or having sustained a
recent hip fracture. The results revealed a similar care
gap, revealing calcium and vitamin D supplementation in
69% of residents and bisphosphonate use in only 19% of
residents [36]. There were wide variations among facil-
ities which ranged from 0-85% [36]. An earlier American
study showed rates of only 11.5% of LTC patients receiv-
ing a bisphosphonate, but their data collection period
spans from 1995-2004 [21], in contrast to the two afore-
mentioned studies which collected data from 2005-2006
and 2003-2004 respectively. This may suggest that
although a care gap indeed still exists, it may have
improved compared to the situation in the 1990’s. Finally,
a recent literature review also showed that the majority
(96%) of studies on osteoporosis treatment was con-
ducted on community-dwelling patients, and often the
exclusion criteria prevented patients who resemble the
LTC population from participating in these studies [37].
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treatment has not focused on the LTC population, and
although we often still apply these practices to the LTC
group, more dedicated research should focus this particu-
larly high risk group.
Some limitations of our study included that the study
was not randomized, the relatively small sample size ana-
lyzed, and the geographic limitation of survey distribution
to only the Hamilton area. Another potential bias is there
may be site specific variability regarding education among
the 8 LTC facilities surveyed. Although none of the 8 facil-
ities provided specific education to their staff regarding
fracture prevention and osteoporosis treatment, there can
still be site specific variability regarding non-dedicated
education. However, the results of this study still does
shed light on our current situation regarding the osteo-
porosis care gap, and may lead to further research into
this particular area in the near future.
Over the last few years, there have been studies emer-
ging to attempt to understand the barriers to imple-
menting the clinical practice guidelines for osteoporosis
care in the LTC population, and further research needs
to be continued in this area. This is quite encouraging,
and only after understanding current practices and
existing care gaps will the development of useful and
well accepted knowledge transfer and guideline imple-
mentation strategies will be possible.
Areas of future research include implementing some
educational initiatives in the LTC facilities and following
up to assess if there is indeed an improvement in
knowledge regarding fracture prevention and osteoporo-
sis treatment. Another important question to address is
if there is indeed an improvement in knowledge, does
this also translate to a change in management of the
LTC patients.
Conclusion
Bisphosphonates are quite effective in increasing the bone
mineral density of LTC patients, and may reduce fracture
rates, but they are only effective if properly administered.
Only 52% of the nurses and 8.7% of PSWs surveyed were
administering the drug properly. In summary, although
the education of health providers has improved since the
mid-1990’s, this area still requires further attention and
the subject of future quality assurance research.
Author details
1Division of Rheumatology and Department of Medicine, St. Joseph’s
Healthcare and McMaster University, Hamilton, Ontario, Canada.
2Departments of Clinical Epidemiology and Biostatistics and Medicine,
McMaster University, Hamilton, Ontario, Canada.
3St Joseph’s Healthcare,
Hamilton, Ontario, Canada.
4Department of kinesiology, Waterloo University,
Waterloo, Ontario, Canada.
5Division of Geriatrics and Department of
Medicine, Hamilton Health Science and McMaster University, Hamilton,
Ontario, CIHR -Eli Lilly Chair Osteoporosis and Fracture Prevention, Canada.
Authors’ contributions
ANL: Role in study design, and drafted the initial manuscript. GI: Performed
statistical analysis, and critically appraised review of the initial draft. YP: Role
in study design, data collection and critically appraised review of the initial
draft. LMG: Role in study design, and critically appraised review of the initial
draft. MVH: Role in study design, and critically appraised review of the initial
draft. JDA: Role in critically appraisal of the initial draft. AP: Role in study
design, and critically appraised review of the initial draft. All authors read
and approved the final manuscript.
Competing interests
Dr. Adachi has received consulting fees from Amgen, Astra Zeneca, Eli Lilly,
Glaxo-Smith Kline, Merck, Novartis, Pfizer, Procter & Gamble, Roche, Sanofi
Aventis, Servier.
A. Papaioannou is or has been a consultant or on the speaker’s bureau for
the following: Aventis Pharma, Eli Lilly Canada Inc., Merck Frost Canada,
Novartis Pharmaceticals Canada Inc., Proctor and Gamble Pharmaceuticals.
All other authors have no financial disclosures.
We would also like to acknowledge funding from the Ontario Ministry of
Health and Long-Term Care Osteoporosis Strategy for this project.*
Received: 19 January 2010 Accepted: 8 October 2010
Published: 8 October 2010
References
1. NIH Consensus Development Panel on Osteoporosis Prevention,
Diagnosis and Therapy. Osteoporosis prevention, diagnosis and therapy.
JAMA 2001, 285:785-795.
2. Nevitt M, Chen P, Dore R, et al: Reduced risk of back pain following
teriparatide treatment: a meta-analysis. Osteoporos Int 2006, 17:273-280.
3. Cooper C, Campion G, Melton LJ III: Hip fractures in the elderly: a world-
wide projection. Osteoporos Int 1992, 2:285-289.
4. Cooper C, Atkinson EJ, Jacobsen SJ, et al: Population-based study
of survival after osteoporotic fractures. Am J Epidemiol 1993,
137:1001-1005.
5. Papaioannou A, Wiktorowicz ME, Adachi JD, et al: Mortality, independence
in living and re-fracture, one year following hip fractures in Canadians.
J Soc Obstet Gynaecol Can 22:591-597.
6. Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, et al: Zoledronic Acid
in Reducing Clinical Fracture and Mortality after Hip Fracture. N Engl J
Med 2007, 357.
7. Cummings SR, San Martin J, McClung MR, et al: Denosumab for
prevention of fractures in postmenopausal women with osteoporosis. N
Engl J Med 2009, 361(8):756-65.
8. Gold DT: The clinical impact of vertebral fractures: quality of life in
women with osteoporosis. Bone 1996, 18(supplement):185S-189S.
9. Matthis C, Weber U, O’Neill TW, et al: Health impact associated with
vertebral deformities: results from the European Vertebral Osteoporosis
Study (EVOS). Osteoporos Int 1998, 8:364-372.
10. Mckercher HG, Crilly RG, Kloseck M: Osteoporosis management in long-
term care. Survey of Ontario Physicians. Canadian Fam Physician 2000,
46:2228-2235.
11. Zimmerman SI, et al: The prevalence of osteoporosis in nursing home
residents. Osteoporosis Int 1999, 9:151-157.
12. Weller I, Schatzker J: Hip fractures and Alzheimer’s disease in elderly
institutionized Canadians. Ann Epidemiol 2004, 14(5):319-324.
13. Chandler JM, Zimmerman SI, Girman CJ, et al: Low bone mineral density
and risk of fracture in white female nursing home residents. JA mM e d
Assoc 2000, 284(8):972-977.
14. Gupta G, et al: Underuse of procedures for diagnosing osteoporosis and
of therapies for osteoporosis in older nursing home residents. Journal of
the American Medical Directors Association 2003, 4:200-202, Gupta 2003.
15. Brennan SJ, Johansen A, Butler J, et al: Place of residence and risk of
fracture in older people: a population-based study of over 65-years olds
in Cardiff. Osteoporos Int 2003, 14(6):515-519.
16. Papaioannou A, Watts NB, Kendlar DL, et al: Diagnosis and management
of vertebral fractures in elderly adults. American Journal of Medicine 2002,
113:220-228.
17. Papaioannou A, Wiktorowicz M, Adachi JD, et al: Mortality, independence
in living, and re-fracture one year following hip fracture in Canadians. J
Soc Obstet Gynecol Can 2000, 22:591-597.
Lau et al. BMC Geriatrics 2010, 10:73
http://www.biomedcentral.com/1471-2318/10/73
Page 6 of 718. Duque G, Mallet L, Roberts A, et al: To treat or not to treat, that is the
question: Proceedings of the Quebec symposium for the treatment of
osteoporosis in long-term care institutions, saint-hyacinthe, Québec,
November 5, 2004. Journal of the American Medical Directors Association
2006, 7:435-441.
19. Streiner DL, Norman GR: Health measurement scales: a practical guide to
their development and use. Oxford, New York. Oxford University Press
2003.
20. Wiktorowicz ME, Goeree R, Papaioannou A, et al: Economic implications of
hip fractures: health service use, institutional care and costs in Canada.
Osteoporos Int 2001, 12:271-278.
21. Parikh S, Mogun H, Avorn J, et al: Osteoporosis medication use in nursing
home patients with fractures in 1 US state. Arch Intern Med 2008,
168:1111-1115.
22. Greenspan SL, Schneider DL, McClung MR, Miller PD, Schnitzer TJ, Bonin R,
Smith ME, DeLucca P, Gormley GJ, Melton ME: Alendronate improves
bone mineral density in elderly women with osteoporosis residing in
long-term care facilities. A randomized, double-blind, placebo-controlled
trial. Ann Intern Med 2002, 136(10):742-6.
23. Wells GA, Cranney A, Peterson J, Boucher M, Shea B, et al: Alendronate for
the primary and secondary prevention of fractures in postmenopausal
women. Cochrane Database Syst Rev 2008, 1:CD001155.
24. Sawka AM, Ismaila N, Cranney A, Thabane L, Kastner M, et al: A scoping
review of strategies for the prevention of hip fracture in elderly nursing
home residents. PLoS One 2010, 5(3).
25. Ioannidis G, Thabane L, Gafni A, et al: Optimizing care in osteoporosis:
The Canadian quality circle project. BMC musculoskeletal disorders 2008,
9:13.
26. Lauritzen JB: Hip fractures. Epidemiology, risk factors, falls, energy
absorption, hip protectors, and prevention. Dan Med Bull 1997,
44(2):155-168.
27. Vu MQ, Weintraub N, Rubenstein LZ: Falls in the nursing home: are they
preventable. J Am Med Dir Assoc 2004, 5(6):401-406.
28. Tinetti ME, Speechley M, Ginter SF: Risk factors for falls among elderly
persons living in the community. N Engl J Med 1988, 319(26):1701-7.
29. Morris JC, Rubin EH, Morris EJ, Mandel SA: Senile dementia of the
Alzheimer’s type: an important risk factor for serious falls. J Gerontol
1987, 42(4):412-417.
30. Komar L, Nieves J, Cosman F, et al: Calcium homeostasis of the elderly
population upon admission to the nursing home. J Am Geriatr Soc 1993,
41(10):1057-1064.
31. Norton R, Campbell AJ, Reid IR, et al: Residential status and risk of hip
frature. Age Aging 1999, 28:135-139.
32. Avenell A, Gillespie W, Gillespie L, O’Connell D: Vitamin D and vitamin D
analogues for preventing fractures associated with involution and post-
menopausal osteoporosis. Cochrane Database Syst Rev 2006, 1.
33. Lee LT, Drake WM, Kendler DL: Intake of calcium and vitamin D in 3
Canadian long-term care facilities. J Am Diet Assoc 2002, 102:244-247.
34. Colon-Emeric C, Lyles KW, Levine DA, et al: Prevalence and predictors of
osteoporosis treatment in nursing home residents with known
osteoporosis or recent fracture. Osteoporosis Int 2007, 18:553-559.
35. Giangregorio LM, Jantzi M, Papaioannou A, et al: Osteoporosis
management among residents living in long-term care. 2009,
20:1471-1478.
36. Colon-Emeric CS, Lyles KW, House P, et al: Randomized trial to improve
fracture prevention in nursing home residents. Am J Med 2007,
120:886-892.
37. Crilly RG, Hillier LM, Mason M, Gutmanis I, Cox L: Prevention of hip
fractures in long-term care: relevance of community-derived data. JA m
Geriatr Soc 2010, 58(4):738-45.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2318/10/73/prepub
doi:10.1186/1471-2318-10-73
Cite this article as: Lau et al.: What are the beliefs, attitudes and
practices of front-line staff in long-term care (LTC) facilities related to
osteoporosis awareness, management and fracture prevention?. BMC
Geriatrics 2010 10:73.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lau et al. BMC Geriatrics 2010, 10:73
http://www.biomedcentral.com/1471-2318/10/73
Page 7 of 7